Results

Total Results: 1,569 records

Showing results for "discussed".

81. CER 210: Disposition of Comments for Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-210-breastfeeding-disposition-comments.pdf
    January 01, 2020 - This is not discussed in the executive summary and is not even mentioned in the text until page 124 … Section Comment Response TEP Reviewer 1 Discussion/ Conclusion One of the biggest limitations not discussed … tables in the executive summary would greatly benefit from the insertion of references for each of the discussed … In this review, I see a few studies discussed in conjunction with other interventions (e.g.

82. Disposition of Comments for CER 172 Clostridium Difficile Diagnosis Prevention Treatment (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/c-difficile-update_disposition-comments.pdf
    March 29, 2016 - Reviewer #3 Results Second, the use of monoclonal antibodies directed against TcdA and TcdB could be discussed … Peer Reviewer #3 Discussion One area that is not discussed explicitly is some of the controversy regarding … This is discussed on page 24. … We have discussed some cost issues for fidaxomicin, as a newly approved but costly treatment. … are somewhat "telegraphic" and could be expanded to give the reader a better idea of what will be discussed

83. Disposition of Comments for Treatment of Glaucoma: Comparative Effectiveness (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_disposition-comments.pdf
    April 01, 2012 - While many of these factors are discussed in the companion review on screening for glaucoma, not all … These results are indeed discussed along with the key point that the assessment of QOL was done after … Concentration of mitomycin is not discussed in the report.(Lee SJ, Paranhos A, Shields MB. … Other similar procedures are not discussed, including Trabectome and endocyclophotocoagulation, which … Public comment/ AAO-AGS Results Key Question3b Aqueous humor shunts are not discussed at all in

84. Behavioral Programs for Type 2 Diabetes Mellitus: Current State of the Evidence (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_clinician.pdf
    November 01, 2016 - Points to be discussed with patients and their caregivers include: ��That some types of behavioral programs

85. Executive Summary_Comparative Effectiveness Review No. 252: Management of Infantile Epilepsies (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-252-infantile-epilepsies-executive-summary.pdf
    October 01, 2022 - We discussed all included studies narratively, and we rated the strength of evidence (SOE) using EPC

86. Disposition of Comments Report for Medication Adherence Interventions: Comparative Effectiveness (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/medication-adherence-interventions_disposition-comments.pdf
    September 11, 2012 - must be acknowledged, and the limitations this imposed on the applicability of the review must be discussed … Already discussed in the first paragraph under methodological limitations Peer Reviewer #9 Discussion … We have discussed this issue under methodological limitations. … summarized some cross-cutting themes in the future research section Richard Chapell Discussion As discussed … above under "Methods," the literature on adherence is considerably larger than the literature discussed

87. Renal Artery Stenosis Management Strategies: An Updated Comparative Effectiveness Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-update_disposition-comments.pdf
    August 16, 2016 - This concept has been discussed in summaries and the Discussion. … We discussed this but have elaborated more fully in the limitations. … Future subanalyses are also now discussed.

88. Disposition of Comments for Evidence Report #208 Part 5 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/public-reporting-quality-improvement_disposition-comments.pdf
    July 26, 2012 - This issue was discussed in the Discussion/ Limitation section. … This is now stated in the introduction and also discussed as a limitation. … This is discussed in the limitations of this review. … Confounding and the difficulty in studying/isolating the impact of public reporting are discussed in … ACS would argue that both of these important findings should be discussed in the AHRQ the report.

89. Disposition of Comments_Systematic Review: Mental Health and Occupational Stress in the Emergency Medical Services and 911 Workforce (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-911-workforce-mental-health-disposition-comments.pdf
    February 28, 2025 - Comments on the Introduction section of the draft report: Employee assistance programs don't seem to be discussed

90. Disposition of Comments Report for Interventions To Improve Patient Adherence to Hepatitis C Treatment: Comparative Effectiveness (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-treatment-adherence_disposition-comments.pdf
    December 20, 2012 - In particular, a number of existing studies have discussed in detail the methods for collecting adherence … One suggestion would be to reframe the outcomes discussed in the results through the KQ for each level … We discussed the limited application of current findings to patients receiving protease inhibitors … We also discussed how the increased pill burden may affect adherence in the future research section … excellent overview of the level of evidence for each key question by group -applicability is clearly discussed

91. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_research-protocol.pdf
    November 30, 2011 - The issue of adherence to antiviral treatment and outcomes was considered and discussed by AHRQ. … effectiveness of different treatment regimens among various patient subgroups defined by the characteristics discussed … Key Informants discussed the importance of a thorough understanding of the comparative effectiveness

92. Disposition of Comments for Pharmacokinetic/Pharmacodynamic Measures for Guiding Antibiotic Treatment for Hospital-Acquired Pneumonia (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_disposition-comments.pdf
    November 24, 2014 - – discussing the increasing incidence of multi drug resistant Gram-negative organisms (partially discussed … included in the background section of the report where optimal dosing based on PK/PD principles is discussed … study, discussion about the major findings were nicely stated and obvious limitations were adequately discussed … During the early stages of the systematic review phase, the key questions were discussed with our Technical … The lack of studies linking PK/PD to clinical (patient-centered) outcomes in this setting has been discussed

93. Disposition of Comments Report for Technical Brief 15 Transition Care for Children With Special Health Needs (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/children-special-needs-transition_disposition-comments.pdf
    June 17, 2014 - We did not limit the types of evidence that could be reviewed and discussed for Guiding Questions … We did not limit the types of evidence that could be reviewed and discussed for Guiding Questions … We did not limit the types of evidence that could be reviewed and discussed for Guiding Questions … As it discussed in many HCT articles, it is critical that the term "transition” and “transfer” are … Peer Reviewer 13 General The limitations of measures (materials) was not discussed.

94. Disposition of Comments for CER 158 Diagnosis of Gout (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-diagnosis-disposition-160727.pdf
    February 24, 2016 - We modified our conclusion about US, and discussed possible reasons for the wide variation in sensitivity … outcome measures are appropriate, although the gold standard itself has it own many limitations as discussed … It is now discussed in the Discussion section (Findings in Relation to What is Already Known). … both parts of the question should be addressed here and these two very separate issues should be discussed … We substantially expanded the Research Gaps section and discussed the issues related to misdiagnosis

95. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_disposition-comments.pdf
    September 01, 2011 - 6 Methods The potential for bias against publication of negative studies should be considered and discussed … Results The likelihood of double-counting, while a possibility, is almost impossible as the studies discussed … the low strength of evidence and then again discussing the limitations/quality of included studies discussed

96. Disposition of Comments Report for Comparative Effectiveness Review 128 Oral Mechanical Bowel Preparation for Colorectal Surgery (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-surgery-preparation_disposition-comments.pdf
    April 30, 2014 - We have discussed designs that can be used to evaluate the effect of oral antibiotics in combination … The issue of VTE was discussed (in varying levels of details) in each of the TEP teleconferences we … We have provided the requested information in the Results section and have discussed its implications … We have discussed the implications of inconsistent reporting the Final Report. … TEP #7 Conclusion The limitations are also properly discussed. Thank you.

97. Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: 2022 Update of the PTSD-Repository Evidence Base (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-dispositIon-comments-2022.pdf
    January 01, 2022 - common in research involving mental health conditions and behavioral interventions but aren’t usually discussed … at length by review authors and I appreciated the transparency and detail with which the authors discussed … PICOTS table, I am unclear when it says “Any overall PTSD outcome,”- what about the other outcomes discussed

98. Disposition of Comments_Comparative Effectiveness Review No. 269_Respectful Maternity Care: Dissemination and Implementation of Perinatal Safety Culture To Improve Equitable Maternal Healthcare Delivery and Outcomes (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-269-respectful-maternity-care-disposition-comments.pdf
    January 02, 2024 - ES Abstract Suggest incorporating into the Conclusions paragraph of the ABSTRACT considerations discussed … As discussed in section 3.3.1, The revised Childbirth experience questionnaire (CEQ- 2) also demonstrates … Suggest incorporating into the Conclusions paragraph of the ABSTRACT considerations discussed later

99. Disposition of Comments: Management of Suicidal Thoughts and Behaviors in Youth (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-youth-disposition-comments.pdf
    April 10, 2025 - At minimum, this needs to be discussed in the paper. … Many health systems and national medical organizations recommend using a variety of the studies discussed … appreciate however pointing out this study, and we have added it to the discussion section and discussed

100. Disposition of Comments for CER 157 Appendicitis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendicitis_disposition-comments.pdf
     December 14, 2015 - We have discussed these potential sources of bias extensively in the Results and Discussion sections … We have discussed these potential sources of bias extensively in the Results and Discussion sections … We have discussed these potential sources of bias extensively in the Results and Discussion sections … We have discussed our meta-regression results more extensively. … This is the key idea behind repeat testing with deferred treatment, an issue that is now discussed